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Obstructive sleep apnea (OSA) is deﬁned by quantifying apneas and hypopneas along with
symptoms suggesting sleep disruption. Subtler forms of sleep-disordered breathing can be
missed when this criteria is used. Newer technologies allow for non-invasive detection of
ﬂow limitation, however consensus classiﬁcation is needed. Subjects with ﬂow limitation
demonstrate electroencephalogram changes and clinical symptoms indicating sleep
fragmentation. Flow limitation may be increased in special populations and treatment
with nasal continuous positive airway pressure (CPAP) has been shown to improve
outcomes. Titrating CPAP to eliminate ﬂow limitation may be associated with improved
clinical outcomes compared to treating apneas and hypopneas.
& 2015 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Severity of obstructive sleep apnea (OSA) has been deﬁned by
the quantity of apnea and hypopnea events (i.e. the apnea/
hypopnea index, or AHI) occurring per hour of recorded sleep.
Early detection of these events was accomplished via the use
of oronasal thermistors. However, this technique cannot
assess for respiratory effort; which has been identiﬁed to
cause frequent arousals from sleep due to intrathoracic
pressure swings that occur with little or no detectable change
in thermistor signals [1–3]. Encephalography (EEG) arousals
occurring in the absence of apneas and hypopneas with
evidence of increased intrathoracic pressure swings can beep. Production and Hosti
licenses/by-nc-nd/4.0/).
edical Center, Departme
uilleminault).
an Association of Sleep.included with AHI to an index known as the respiratory
disturbance index (RDI). Elevation of RDI without signiﬁcant
increase in AHI is suggestive of upper airway ﬂow limitation
and clinically can be diagnosed as upper airway resistance
syndrome (UARS). The International Classiﬁcation of Sleep
Disorders has placed UARS in the diagnostic category of OSA
disorders [4]; however UARS may be more challenging to
diagnosis. Diagnosis requires evidence of intrathoracic pres-
sure changes culminating in arousals, deﬁned as a respira-
tory effort related arousal (RERA), versus signiﬁcant
quantiﬁable reductions in air ﬂow seen in OSA [5]. While
there is strong evidence highlighting the cardiovascular risk
of OSA [6,7], it has been proposed that other forms of sleepng by Elsevier B.V. This is an open access article under the CC BY-
nt of Sleep Medicine, 450 Broadway, M/C 5704, Redwood City, CA
Fig. 1 – Airﬂow and esophageal pressure monitoring on PSG.
(A) A central event with reduction in airﬂow without any
change in esophageal pressure signal during the event. (B) A
reduction in airﬂowwith an increase in esophageal pressure
for the duration of the event, indicative of an obstructive
hypopnea. Flattening of the airﬂow signal can also be seen
during the obstructive event suggestive of ﬂow limitation.
S l e e p S c i e n c e 8 ( 2 0 1 5 ) 1 3 4 – 1 4 2 135disordered breathing (SDB) such as UARS can be correlated
with excessive-daytime-sleepiness – EDS [8–10], long-term
cardiovascular complications [11,12] and signiﬁcant costs to
society [13–15].
The ﬁnding of RERAs has increased the sensitivity of diag-
nosing SDB, especially in individuals with a high clinical suspi-
cion without polysomnogram (PSG) data supporting a clear
diagnosis of OSA. The reference measurement for respiratory
effort and intrathoracic pressure is esophageal pressure mon-
itoring [16]. Chervin et al. showed a decreased esophageal
pressure nadir and less sleep time with esophageal pressure
more negative than 10 cm of water after adenotonsillectomy in
children, suggestive of improved upper airway resistance after
this procedure [17]. In clinical practice, the usage of respiratory
inductance plethysmography (RIP) is accepted for measurement
of respiratory effort in place of esophageal pressure monitoring
by measuring thoraco-abdominal excursion during breathing
versus direct measurement of intrathoracic pressure [18]. The
principle of diagnosing SDB beyond quantitative airﬂow reduc-
tions remains important for recognition of the full spectrum
pathology.
Inspiratory ﬂow limitation (IFL) can be observed as ﬂatten-
ing of the ﬂow tracing on PSG. Physiologically, IFL indicates
absence of an increase in ﬂow despite an elevation in
negative intrathoracic pressure indicating increasing effort
[19]. Condos described this phenomenon during his study
when titrating continuous positive airway pressure (CPAP) to
where the inspiratory ﬂow was rounded rather than pla-
teaued. The ﬂattening of the inspiratory ﬂow is related to
resistance of the airway which can occur even with applica-
tion of positive airway pressure [20]. The presence of inspira-
tory ﬂow limitation is vital to the understanding of UARS and
subsequently as a diagnostic tool for this population.
This review on inspiratory ﬂow limitation is intended to
increase awareness of this entity, its diagnosis, and its
clinical relevance. The current system using apneas and
hypopneas does not capture all individuals who may be
suffering from clinically signiﬁcant respiratory disturbances
during sleep. Often the most challenging cases faced by sleep
medicine clinicians are patients with “normal” PSG ﬁndings
despite presenting with symptoms consistent with OSA. With
improved diagnostic measures and understanding of IFL,
opportunities for successful treatment may follow.2. Detection of IFL
Assessing for inspiratory ﬂow limitation requires recognition of
both ﬂow and intrathoracic pressure changes [21]. A decrease in
ﬂow normally is accompanied by a compensatory increase in
intrathoracic pressure. This is illustrated in Fig. 1 in the setting
of differentiating a central and obstructive event via airﬂow and
esophageal pressure monitoring [18]. Inspiratory ﬂow limita-
tion, which does not meet criteria for an obstructive hypopnea
is illustrated in Fig. 2. Esophageal pressure monitoring, by
demonstrating intrathoracic pressure changes before EEG arou-
sal, remains key in the clinical diagnosis of UARS [9]. As
esophageal pressure monitoring may be uncomfortable and is
not practical for routine monitoring, different methods oﬁden-
tiﬁcation are needed. Conventional pneumotachography hasdemonstrated that plateaus on inspiratory ﬂow waveforms
correlate with elevated upper airway resistance [20–22]. Similar
to esophageal pressure monitoring, routine application of
pneumotachography is limited by discomfort with the monitor-
ing equipment [22]. Respiratory-Inductance-Plethysmography –
RIP-has also been shown to be effective for evaluation of upper
airway resistance, however there is difﬁculty in ensuring an
accurate tidal volume measurement when using this measure
alone [23].
Many studies have been done assessing nasal cannula/
pressure transducer system as a non-invasive assessment of
IFL, in addition to its role in detection of hypopneas and
apneas [2,3,21,22,24]. Ayappa et al. hypothesized that by
assessing the contour of ﬂow shape, rather than amplitude
of signal, respiratory effort could be detected with similar
accuracy to Pes. . Ayappa showed that assessment of RERAs
via ﬂattening of the waveform contour was nearly identical to
the detection by Pes, with interclass correlation coefﬁcient of
0.96 [24]. In addition, Hosselet showed that upper airway
resistance is increased in ﬂow limited breaths by as much as
387% [2].These results suggest that esophageal pressure
monitoring may not be required in assessing for inspiratory
effort, and that further evaluation of waveform contour via
routinely applied nasal cannula/pressure transducer could
reveal these very important events.
Comparison of different monitoring measures has been
done since Ayappa's study showing promise of the nasal
cannula/pressure transducer. Johnson et al. stimulated upper
airway resistance in normal subjects with alcohol consump-
tion and compared nasal cannula/pressure transducer with
Pes, respiratory inductive plethysmography and a fourth
method including a piezo-electrically treated stretch sensor
adhered to the supraclavicular fossa. It was shown that nasal
cannula/pressure transducer was superior to all tested mod-
alities in detecting arousals secondary to increased upper
airway resistance. Surprisingly, many events culminating in
Fig. 2 – Polysomnographic recording of a subject with snoring and inspiratory ﬂow limitation during slow-wave sleep. There
is no ﬂuctuation in oxygen saturation on pulse oximetry however ﬂattening of the nasal waveform, coinciding with snoring,
is present.
S l e e p S c i e n c e 8 ( 2 0 1 5 ) 1 3 4 – 1 4 2136arousals were not associated initially with an increase in
negative intraesophageal pressure detected by Pes; and over
90% of arousals were preceded initially by ﬂow limitation
seen via nasal pressure transducer [25].
It has been shown that additional metabolic factors exist
for increasing respiratory effort during ﬂow limited breathing.
Rimpila et al. researched the relationship between transcu-
taneous carbon dioxide (tcCO2) level, ﬂow limitation, and
respiratory effort during sleep. It was found that ﬂow limita-
tion associated with increased respiratory effort correlated
with tcCO2 above an individual's steady state during sleep.
The authors noted that ﬂow changes did exist below this
tcCO2 threshold, however not with an increase in respiratory
effort. It was concluded that carbon dioxide level can also be
utilized to evaluate for ﬂow limitation, and that ﬂattening of
ﬂow contour exists without an increase in respiratory effort
likely due to stabilization of breathing during sleep [26].
Abnormal ﬂow limitation requires arousal and effort changes;
therefore this type of ﬂattening of the waveform without an
increase in effort cannot be a scorable event. Carbon dioxide
surrogate markers add to the understanding of ﬂow limita-
tion and respiratory effort, and raises questions regarding
whether isolated ﬂow limitation without RERAs or increase in
arterial carbon dioxide is pathological.
Attended CPAP titration and auto-titrating CPAP provides
useful insights regarding the treatment and automated algo-
rithms for detecting IFL, respectively. Condos has shown thatrounded inspiratory ﬂow contour with higher CPAP pressures
correlates with a lower upper airway resistance. Lower CPAP
pressures demonstrate higher upper airway resistance and a
plateaued ﬂow contour, illustrated in Figs. 3 and 4. Flow
limitation occurred when CPAP pressure when lowered con-
current with an increase in negative esophageal pressure,
illustrated in Fig. 4 [20]. This work has been replicated by
Montserrat et al. concluding that the rounded contour of
inspiratory ﬂow correlates with lowest esophageal pressure
in CPAP titration [27]. With auto-titrating CPAP, a pro-
grammed algorithm is used to detect subtle airﬂow abnorm-
alities; which differ by manufacturer of the device. This can
include automated comparison of ﬂow by the device with
stored templates and corresponding actions, ongoing evalua-
tion of ﬂow contour with increase in pressure when ﬂattening
is detected, or small ﬂuctuations in pressure delivery to
determine the optimal pressure setting where no further
improvement is ﬂow shape identiﬁed. While cessation of
apnea can be done with relative ease independent of algo-
rithm used, each one detects IFL differently [28].
Accurate visualization of the ﬂow contour by nasal can-
nula/pressure transducer may be compromised with exces-
sive ﬁltering. Sampling rate should be at least 100 hZ to
obtain accurate ﬂow contour as has been described in the
AASM scoring manual. Finally, the usage of PAP devices
during PSG to assess for ﬂow limitation may also be challen-
ging depending on the PAP and PSG systems used.
Fig. 3 – (with permission) from: Condos et al. (1994) [20]:
Relationship between applied CPAP pressure and
estimated resistance in data from a representative patient.
Insets represent superimposed breaths from the areas
circled on the left. Increase in PAP pressure improves nasal
waveform and decrease in measured resistance.
Fig. 4 – (with permission) from: Condos et al. (1994) [20]:
Continuous tracing of ﬂow in one patient during transition
to lower CPAP. At the arrow, CPAP was lowered by 1 cm H20.
Note the increase in the esophageal pressure swings that
occurs over ﬁve breaths and results in more than a twofold
increase in estimated resistance. Simultaneously, the
inspiratory ﬂow contour loses its rounded shape and
develops the characteristic plateau of ﬂow limitation. )
Table 1 – Classes of inspiratory ﬂow shapes.
Class Description Interpretation
1 Sinusoidal Normal inspir
2 Two peaks during inspiration Upper airway
3 Three or more (tiny) peaks Soft-tissue vib
4 Peak during the initial phase followed by a
plateau
Initial opening
5 Peak at midinspiration with plateau on
both sides
Signiﬁcance u
midinspiration
6 Peak during late phase preceded by a
plateau
Marked trache
7 Plateau throughout inspiration Collapse of no
S l e e p S c i e n c e 8 ( 2 0 1 5 ) 1 3 4 – 1 4 2 137Despite extensive literature supporting non-invasive tech-
niques to assess for IFL as referenced above, this still requires
manual visualization of breathing during PSG which can lead
to differences in qualifying breaths as ﬂow limited between
physicians and technicians scoring events. A degree of uni-
formity regarding identiﬁcation of ﬂow limitation is needed;
and a standardized approach to visual recognition of IFL will
be vital. Objective quantiﬁcation of ﬂow limitation based on a
mathematical formula using supraglottic pressure and ﬂow
data has been done, which aims to resolve the conﬂict of
subjective differences [29]. Progress has been made to
develop an automated system of calculating ﬂow limitation
using mathematical algorithms of pressure/ﬂow relationship
and waveform contour. As an example, Morgenstern et al.
reports on development of a classiﬁer to detect ﬂow limita-
tion non-invasively with sensitivity and speciﬁcity above
manual scoring of events [30]. With a reﬁned algorithm for
detecting IFL using an upper airway pressure/ﬂow relation-
ship in addition to waveform contour, it is plausible that new
auto-titrating CPAP algorithms can be programmed that treat
IFL as effectively as obstructive apneas.3. Characterization of IFL
A study in Turku, Finland demonstrated the spectrum of
inspiratory ﬂow signal shapes in patients with partial upper
airway obstruction during sleep [31]. The upper airway is
submitted to at least three forces during inspiration: phasic
activity of the dilator muscles (activated at or prior to the
onset of inspiration), negative airway pressure (maximal at
mid-inspiration), and tracheal traction support (maximal at
end-inspiration) [32,33]. The investigators reasoned that the
inspiratory ﬂow shape could provide information on upper
airway behavior throughout inspiration, similar to ﬂow-
volume loops in pulmonary function testing.
Postmenopausal women and male patients with established
OSAS treated with uvulopalatopharyngoplasty were selected as
patient groups. A control group was also selected. Inspiratory
ﬂow signals were evaluated on a breath-by-breath basis, and
each inspiratory ﬂow shape was extracted from an automated
classiﬁer. Recorded breaths were sorted into 7 classes of
inspiratory ﬂow shapes with their signiﬁcance as it relates to
anatomic ﬂow abnormality (Table 1, Fig. 5). Based on the resultsFlow
limitation
ation No
reopening after initial collapse Yes
ration during inspiration Yes
indicates effective phasic upper airway dilation Yes/No
ncertain; intensive phasic muscle activity at
(?)
Yes
al traction support during lung inﬂation Yes
ncompliant upper airway Yes
Fig. 5 – (with permission) from: Aittokallio et al. (2001) [30]:
The distribution of ﬂow shape classes in experimental and
control subjects.
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patient group, but also between males and females [31].
While this study attempts to classify ﬂow data, correlate
them with anatomical changes in the pharyngeal airway and
whether it signiﬁes ﬂow limitation, the authors conclude that
physiologic meanings cannot be reliably ascertained based on
their ﬁndings alone. This work does provide a framework on
which to characterize ﬂow limitation and subsequently increase
understanding of upper airway dynamics during sleep. Auto-
mated classiﬁcation of inspiratory ﬂow signals will need to be
reinforced by similar manual classiﬁcation in order to create a
reproducible scoring system for characterizing ﬂow limitation.4. Epidemiology of IFL
A study using a representative population sample based on a
census of Sao Paolo, Brazil evaluated the distribution of IFL in
asymptomatic versus symptomatic subjects [34]. The goal
was to deﬁne how much IFL exists in the general population
and to determine a threshold beyond which IFL is considered
pathologic.
The study took advantage of an existing epidemiologic
cohort of 1,101 individuals who had undergone PSG to identify
normal asymptomatic subjects. Subjects with moderate-to-
severe OSA were excluded from the analysis, as IFL is unne-
cessary to support the diagnosis in these cases and tends to be
absent in cases where apnea predominates. The scoring of IFL
was performed manually by visual inspection. Periods of IFL
were deﬁned as at least four consecutive breaths showing
inspiratory ﬂattening of the airﬂow curve that did not meet
criteria for hypopnea. Three scorers evaluated 20 studies and
the inter-scorer agreement rate for percent rate of IFL was 0.950
(po0.001). The normal group (n¼163) was deﬁned by the
following criteria: (1) no known diagnosis of a sleep disorder
or sleep complaints, (2) no OSA according to International
Classiﬁcation of Sleep Disorders (ICSD-2) criteria, and (3) no
signiﬁcant primary lung disease.
In the normal group, the 95th percentile for IFL was 31%.
This percentage did not show a clear correlation with an
increase in age, but it was signiﬁcantly correlated with BMI.
These results suggest that only IFL values greater than 30%should be used to support the diagnosis of SDB. Conversely,
the IFL pattern cannot be used exclusively to determine
abnormality, as roughly 5% of the normal population has
IFL greater than 30% of the night. Despite these limitations,
and lack of studies correlating IFL percentage with clinical
symptoms, discussing IFL on PSG reports provides a metric
that may be clinically relevant; especially in the absence of
signiﬁcant elevation of AHI.5. IFL-related EEG changes during sleep
In prior studies, it has been demonstrated that UARS patients
have an important disruption of sleep EEG with a continuous
increase in fast range EEG frequencies, and that the sleep EEG
is as disturbed with continuous IFL as it is with repetitive
hypopneas [35,36]. Black et al. showed that patients with SDB,
predominantly IFL, did not re-open their airway only with
presence of an alpha EEG burst; but often upper airway re-
opening occurred in association with a burst of delta [37]. An
alpha rhythm often followed the delta burst, but was com-
monly very short and did not respond to the deﬁnition of the
EEG arousals from the AASM.
A large amount of work has been performed indicating that
disturbance of sleep based on the sleep-EEG analysis did not
respond to the deﬁnition of the EEG arousal [38]. Deﬁnitions of
disturbance of sleep EEG based on speciﬁc patterns seen during
non-rapid eye movement (NREM) sleep were tested and pub-
lished under the label of “cyclic alternating pattern” or CAP. The
CAP is a periodic EEG activity of NREM sleep characterized by
sequences of transient electro-cortical events that are distinct
from background EEG activity and recur at up to 1-min intervals
as seen in Fig. 6 [39]. CAP activity may signify sleep stage
instability, sleep disturbance, or both.
A prospective, single-blinded study compared the CAP rate
of subjects with UARS and controls [40]. Results of CAP analysis
demonstrated a signiﬁcant reduction in NREM sleep, an ele-
vated CAP rate, and an increase in EEG arousals based on CAP
rate analysis. There was a signiﬁcant positive correlation
between CAP rate and Epworth sleepiness scale (ESS) score.
Another study sought to deﬁne the relationship between
chronic fatigue, unrefreshing sleep, and abnormal SWS invol-
ving symptomatic and asymptomatic (control) subjects by
evaluating breathing using nasal cannula and Pes [36]. After
performing conventional PSG scoring, Fast Fourier Transfor-
mation (FFT) was applied for investigation of the sleep EEG
frequency bands. Symptomatic subjects presented an abnor-
mal amount of IFL detected by nasal cannula monitoring and
abnormal Pes recording providing evidence of increased
inspiratory efforts. There was nocturnal sleep disturbances
with reduction of SWS and sleep efﬁciency, increase in CAP
rate, and FFT analysis showed an abnormal increase of the
delta-1 (0.5–2 Hz) band with decrease in all other EEG bands
compared to controls.
Guilleminault et al. also conducted a study involving OSA
split into a hypopnea and apnea-hypopnea subgroup, UARS
patients and an asymptomatic normal breathing control
group matched for age and body-mass-index. The study
compared the nocturnal sleep EEG after treatment using
FFT to dissociate the different EEG band activity using a
Fig. 6 – Polysomnographic recording demonstrating the cyclic alternating pattern in NREM sleep. Distinct change in EEG
activity is seen in association with snoring and separated by a homogenous background activity without snoring.
S l e e p S c i e n c e 8 ( 2 0 1 5 ) 1 3 4 – 1 4 2 1394 min over-lapping time-window [40]. All SDB groups had a
signiﬁcantly different sleep EEG than controls, but the UARS
patients were also signiﬁcantly different than both OSA
patients groups: There was a signiﬁcant increase in both
delta and alpha bandwidth powers in UARS compared to
OSA, and a much higher alpha power with less delta power
than controls. The conclusion of the authors was that the
UARS patient demonstrated less sleep disturbance when
considering the bands other than alpha, but had a much
more “alert type” of EEG during the total sleep time with
much higher alpha relative power leading to a maintenance
of air exchange at the cost of continuous near-awakening.
These studies suggest that IFL is associated with EEG
abnormalities that are likely clinically signiﬁcant, however
are not currently recognized as scorable events. Recognition
of IFL on a qualiﬁable level in conjunction with associated
EEG changes provides a deeper understanding of more subtle
forms of SDB. This spectrum of airﬂow and EEG changes
taken together allow for increasing sensitivity in diagnosing
SDB beyond apneas.6. IFL is associated with clinical symptoms
The bulk of research identifying comorbidities with SDB has
focused on apnea and hypoxia. However, there is evidence
that IFL and sleep fragmentation also may lead to problems.
Patients with UARS, deﬁned by the presence of IFL associated
with EEG arousal [5], suffer from sleep disruption and poorerquality of life [41]. SDB also has been linked to insomnia,
daytime fatigue and unrefreshing sleep [42]. Prior studies
have demonstrated that in mild SDB with diagnosed insom-
nia, treatment of SDB in addition to targeted cognitive
behavioral therapy leads to superior outcomes than cognitive
behavioral therapy alone [43,44].
It is important to note that thermistors were used in many
studies identifying the pathologic associations of IFL. Many
events characterized by thermistors as IFL today may be
classiﬁed as hypopneas. While clear association between
isolated IFL and clinical symptoms have not been reported,
there is extensive literature outlining both positive and
negative effects of arousal from sleep; which can be seen as
a consequence of IFL. Eckert and Younes outlined these
effects summarizing that overall the effects of arousal during
sleep associated with obstructed breathing are negative.
While restoration of airﬂow associated with arousal treats
hypoxemia associated with obstruction, the frequency of
arousals disrupt sleep and prevent natural progression to
deeper stages of sleep [45]. In the population presenting with
insomnia and fatigue, frequent arousals during sleep asso-
ciated with IFL can explain symptoms often attributed to
etiologies not related to sleep.7. IFL in special populations
Further work has been done delineating an association
between functional somatic syndrome, anxiety disorders
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mic–pituitary axis activity related to the effects of SDB
creating a ﬁnal common pathway of functional somatic
syndrome and anxiety disorders; including but not limited
to chronic fatigue syndrome, ﬁbromyalgia, chronic migraine/
tension headache and irritable bowel syndrome [46]. Gold has
previously shown that patients with UARS complain of
symptoms consistent with functional somatic syndrome
more than patients with OSA [47]. This further reinforces
the importance of comprehensive sleep monitoring in
patients that may not present with classic symptoms of an
obstructed airway. Research has shown that treatment of
upper airway resistance has led to improved subjective
measures of pain and fatigue in patients with chronic
sinusitis [48,49]
Snoring is common in pregnant women [50,51]. Pre-
eclampsia is a syndrome that is potentially fatal for both
fetus and mother. It is related to an anomaly of insertion on
placenta and associated with elevated BP that is apparent
during second half of pregnancy. Edwards et al. showed that
inspiratory ﬂow limitation is common in patients at time of
preeclampsia, and that short-term nasal CPAP is associated
with a reduction in nocturnal blood pressure [52].
Connolly et al. conducted a prospective case control study
involving normal non-pregnant women, normal pregnant
women from each trimester and women with preeclampsia
[53]. None of the preeclampsia patients had hypertension
prior to pregnancy. All subjects underwent overnight PSG and
in addition to differentiating apneas and hypopneas, a ﬂow
limitation index (“ﬂattening index”) was calculated [54]. Each
subject also had overnight intermittent blood pressure mon-
itoring. Patients with preeclampsia spent almost one-third of
the sleep period with evidence of IFL, compared to 15% in
normal third-trimester women, 4.6% in normal second-
trimester woman, 3.7% in normal ﬁrst-trimester woman,
and 1.6% in normal controls. Poyares et al. performed a
randomized prospective study placing 50% of women with
hypertension early during pregnancy considered “at risk for
pre-eclampsia” on nasal CPAP. All women received alpha-
methyl-dopa for their hypertension. Women with nasal CPAP
had progressive decrease in usage of hypertensive medica-
tion, normal pregnancy, delivery and normal infants at one
month of age; women in the non-treatment group had
presence of IFL and/or some hypopnea during sleep, wor-
sened blood pressure control, infants smaller than predicted
based on gestational age and more medical visits during ﬁrst
month [55]. Further study is needed to deﬁnitively associate
IFL with pathophysiologic mechanisms in preeclampsia,
especially due to the multi-factorial nature of this condition.8. Evidence supports the use of ﬂow limitation
in diagnostic criteria for sleep-disordered—
breathing-SDB
While there is ample evidence that excessive ﬂow limitation
is abnormal and leads to pathologic changes in sleep and
wakefulness, it is currently unclear whether including this in
the diagnostic criteria for OSA would have any value. There
are many available metrics to qualify SDB; including apneas,hypopneas, oxygen desaturation and arousals. Studies in
children and adults have been conducted to demonstrate
that the current criterion most commonly used to score
abnormal breathing during sleep is inappropriate. These
studies were based on several investigations in patients
treated for only some of the abnormal breathing patterns
during sleep; supporting the role of ﬂow limitation as a
breathing pattern important to recognize and treat for opti-
mal clinical outcomes [31,45,56–59].
As previously stated, investigation of the general popula-
tion regarding the presence and quantity of ﬂow limitation
and study of health complaints in this sample has been a
second approach done by Palombini et al. [34]. In addition,
Meurice et al. conducted an experiment in which two groups
of patients diagnosed with OSA were treated with different
CPAP pressures. The ﬁrst group was treated with CPAP
pressures targeted to eliminate ﬂow limitation and the
second group treated with CPAP pressures targeted to treat
apneas, hypopneas and snores. The pressure requirements
for the ﬁrst group were higher than for the second group;
however the ﬁrst group had an increase in sleep time and
more consistent improvement in maintenance of wakeful-
ness testing [59]. These results are suggestive that titration to
eliminate ﬂow limitation would lead to improved clinical
outcomes.
The ﬁndings by Palombini and Meurice are further rein-
forced by work done by Hosselet and illustrate the need for
classiﬁcation systems including abnormal ﬂow limitation.
Hosselet et al. looked at different indices based on different
deﬁnitions of abnormal breathing patterns in conjunction
with complaints of EDS and subjects without complaints of
EDS [56]. A receiver operator curve (ROC) was constructed for
each deﬁned index, and cut points were chosen to optimize
the separation between EDS and non-EDS groups. The opti-
mal cutoff for separating subjects with and without EDS was
then chosen based upon calculated sensitivity and speciﬁcity.
The authors had an index where all abnormal breathing
patterns (apnea–hypopnea, ﬂow limitation) were included,
referred to as the RDITotal; the study demonstrated that
RDITotal provided a better sensitivity and speciﬁcity than the
other studied index, the most commonly used AHI.9. Conclusion
Categorizing SDB using measures related only to reduction in
airﬂow does not encompass the range of upper airway
abnormalities, and further categorization of the full spectrum
of abnormalities is needed. While many tools are available for
determining respiratory effort and airﬂow, measurement of
nasal ﬂow by a nasal cannula pressure transducer permits
recording of the respiratory ﬂow curve. The ﬂow tracing
generated has a consistent relationship with upper airway
resistance; and therefore can help assess for pathological IFL
when used in conjunction with other variables, such as EEG
tracing and tcCO2, in patients with mild SDB.
Analysis of multiple indices for quantifying recorded SDB
has shown that scoring ﬂow limitation events in addition to
apneas and hypopneas has a better sensitivity and speciﬁcity
of correlating symptoms with their respiratory causes than
S l e e p S c i e n c e 8 ( 2 0 1 5 ) 1 3 4 – 1 4 2 141currently used strategies. In particular, it is necessary to
detect more subtle forms of SDB such as IFL in certain patient
populations that do not present with frank apneas. Standar-
dized IFL scoring should lead to better detection and char-
acterization of IFL. A reasonable threshold to deﬁne abnormal
IFL would be greater than 30% of sleep, however other
quantiﬁable techniques should be considered. While there
is data that IFL may be linked to clinical consequences in
certain circumstances, more research is needed to establish
guidelines in reproducible scoring of IFL. In addition, further
evidence of its negative health associations are warranted
before routinely incorporating into PSG interpretation.Conﬂict of interest
None.
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